Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGENITOR: Autologous CD133+ Cells in Refractory Angina
NCT00694642Phase 2Completed
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of selected CD133+ cells in Angina Pectoris (AP). Started May 2008; status: completed.
02
Drugs
selected CD133+ cells
03
Conditions
Angina Pectoris (AP)
Beyond the preview
Go deeper on NCT00694642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694642.